 |
Turna Ray is the editor of GenomeWeb's Pharmacogenomics Reporter. She covers pharmacogenomics, personalized medicine, and companion diagnostics. E-mail Turna Ray or follow her GenomeWeb Twitter account at @PGxReporter. |
CMS Stance on Reimbursement of Multi-Analyte Algorithm Assays Raises Industry Concerns
September 19, 2012
CMS Stance on Reimbursement of Multi-Analyte Algorithm Assays Raises Industry Concerns
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- CMS Seeks Stakeholder Input on Gene Test Reimbursement, Maintains Code Stacking for 2012
June 22, 2011 / Pharmacogenomics Reporter - In Information-Gathering Mode, CMS Undecided on Payment Structure for Genetic Tests
July 20, 2011 / Pharmacogenomics Reporter - AMA Threatens to File HIPAA Complaint Unless CMS Halts Program Requiring Z-Codes for MDx Tests
January 4, 2012 / Pharmacogenomics Reporter - Palmetto Issuing 'Z-Codes' to Track Molecular Dx Utilization, Gather Data CPT Codes Can't Provide
November 16, 2011 / Pharmacogenomics Reporter - CMS Issues Pricing for MDx Codes; Labs, Test Developers Still Critical of Rates and Methodology
May 22, 2013 / Pharmacogenomics Reporter